United Kingdom· GB-APID-39488711000001101

Amikacin 500mg/2ml solution for injection vials

A amikacin product containing amikacin, registered in United Kingdom by Tillomed Laboratories Ltd. The same ATC class is registered in 15 of our 19 countries.

ATC J01GB06

Checked against NHS dm+d (United Kingdom) on September 13, 2026

Informational only — not a medical device.

Compare price across countriesPer daily dose · free account Ask the assistant about amikacinAnswers with sources · free account Check interactionsSeverity free · mechanism on Growth

Where it is registered

Amikacin is registered in 15 of 19 countries.

Countries holding a registration under ATC J01GB06 (amikacin), each read from that country’s own register.

This record: United Kingdom, from NHS dm+d (United Kingdom)
8 of them publish a price we can compare per daily dose

Search amikacin products by name

Amikacin · ATC J01GB06

15 / 19 countries

Belgiumprice
Canada
Czechiaprice
Denmark
Finlandprice
Germany
Icelandprice
Ireland
Italyprice
Japan
Netherlands
Norwayprice
Polandprice
Switzerlandprice
United Kingdom

Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

The record

At a glance

NHS dm+d (United Kingdom)

Active substance: Amikacin
Manufacturer: Tillomed Laboratories Ltd
Country: United Kingdom (GB)
ATC code: J01GB06
ATC class: Amikacin
Defined daily dose: 0.59 g, Inhal
Reimbursed: Not published by this register
Source register: NHS dm+d (United Kingdom)
Last checked: September 13, 2026

Packs & prices · 1

gtin
5024655005659

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Interactions

253 interactions on record for amikacin.

Graded by severity as the source publishes them — 50 severe. Severity grades are free for everyone; mechanism and management come with Growth.

Severity for every pair — free, no plan needed
The source, licence and sync date on every record
Mechanism and what to do for each pair — Growth plan

Check amikacin against other medicines How interaction checks work

Amikacin · interactions on record

253 records

50 severe
133 moderate
2 minor
68 info

Most severe, free to view

Magnesium sulfateA06AD04severe
MannitolA06AD16severe
Polymyxin BA07AA05severe
Magnesium sulfateA12CC02severe

Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.

Mechanism and what to do, in the interaction check

Source: DDInter 2.0 · synced 29 Sept 2026. Grades as the source publishes them.

Same medicine, other countries

Amikacin in 16 other countries

What each register calls a product with the same active substance — salts and hydrates count as the same.

All amikacin products

Authorised across Europe · EMA

The same active substance is authorised in 30 EEA countries. Names it is sold under:

Austria · Amikacin B. Braun
Belgium · Amikacine B. Braun, Amikacine Fresenius Kabi
Bulgaria · Amikacin Kabi, Амикацин Б. Браун
Cyprus · Amika-Synto, Amikacin Vioser
Czechia · Amikacin B. Braun, Amikacin Fresenius Kabi
Germany · Amikacin B. Braun, Amikacin Eberth
Denmark · Amikacin Afortas, Amikacin Macure
Estonia · Amikacin B. Braun
Spain · Amicacina, Amicacina B. Braun
Finland · Amikacin Afortas, Amikacin Macure
France · Amikacine B. Braun, Amikacine Kabi
Greece · Amicasil, Amikacin Anfarm
Croatia · Amikacin Zentiva
Hungary · Amikacin Anfarm, Amikacin B. Braun
Ireland · Amikacin, Amikacin Athlone Pharmaceuticals
Iceland · Arikayce Liposomal
Italy · Amicasil, Amikacina B. Braun
Liechtenstein · Arikayce Liposomal
Lithuania · Biodacyna
Luxembourg · Amikacin B. Braun, Amukin
Latvia · Amikacin B.Braun
Malta · Amikacin Tillomed Laboratories, Uzix
Netherlands · Amikacine Hospira
Norway · Amikacin Afortas, Amikacin Macure
Poland · Amikacin B. Braun, Amikacin Kabi,
Portugal · Amicacina Hikma, Amicacina Kabi
Romania · Amikacin Noridem, Amikacină Atb
Sweden · Amikacin Afortas, Amikacin Fresenius Kabi
Slovenia · Amikacin Kabi
Slovakia · Amikacin B. Braun, Amikacin Fresenius Kabi

Source: European Medicines Agency, Article 57 product data.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of NHS dm+d (United Kingdom). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload

GET /v1/drugs/e1460f63-c672-45f8-b0c4-910096a579f6
GET /v1/drugs/e1460f63-c672-45f8-b0c4-910096a579f6?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "apid": "39488711000001101",
  "desc": "Amikacin 500mg/2ml solution for injection vials (Tillomed Laboratories Ltd)",
  "form": "Solution for injection",
  "vpid": "35899911000001109",
  "source": "dmd",
  "vtm_id": "774534000",
  "strength": "250 mg",
  "substance": "Amikacin",
  "ingredient": "Amikacin sulfate",
  "supplier_code": "2089201000001102"
}

API reference MCP server Plans

See everything about amikacin.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.

Try it free Open in the console